Royalty Pharma plc Company Information

Royalty Pharma plc's employee growth, exchange listings and data sources

Key Information

  • Name: Royalty Pharma plc
  • Ticker: RPRX
  • Exchange: NasdaqGS
  • Founded: 1996
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$16.824b
  • Market Cap: US$12.579b
  • Shares Outstanding: 597.43m
  • Website:


  • Royalty Pharma plc
  • 110 East 59th Street
  • New York
  • New York
  • 10022
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RPRXNasdaqGS (Nasdaq Global Select)YesClass A Ordinary SharesUSUSDJun 2020
RPRX NBMV (Bolsa Mexicana de Valores)YesClass A Ordinary SharesMXMXNJun 2020
RPDMUN (Boerse Muenchen)YesClass A Ordinary SharesDEEURJun 2020
RPDDB (Deutsche Boerse AG)YesClass A Ordinary SharesDEEURJun 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/22 00:00
End of Day Share Price 2024/04/19 00:00
Annual Earnings2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.